Editor's Note :

Editor's Note :

This week the blog will publish a multi-part online symposium on United States v. Texas, a challenge by Texas and twenty-five states to the Obama administration's deferred-action policy for immigration. Contributions to this special feature, as well as an “explainer” by this blog's Lyle Denniston, are available here.

Susan McBee and Bryan Jones Guest

Susan McBee is the Chair of the Life Sciences Intellectual Property Team for Baker, Donelson, Bearman, Caldwell, and Berkowitz, P.C. Ms. McBee concentrates her practice in the field of chemistry and biochemistry. She has over 15 years of experience in patent and trademark portfolio management for large Fortune 500 companies. She also has extensive experience with both ex parte and inter partes reexamination proceedings at the U.S. Patent and Trademark Office (USPTO) both as representing patentees as well as third party requestors. Before becoming a patent attorney, Ms. McBee owned a patent search company and worked as a patent examiner at the USPTO in the field of polymer chemistry/light sensitive materials.

Bryan Jones is a registered patent attorney in the Washington D.C. office of Baker, Donelson, Bearman, Caldwell, and Berkowitz, P.C. Mr. Jones has advised clients regarding procurement, defense, and enforcement of patents and trademarks in the biotechnological, metallurgical, pharmaceutical, nutraceutical, and crop sciences.

Date Post Title
02.07.13 The Supreme Court should be mindful of naturally derived products other than nucleic acids when deciding Myriad
Term Snapshot
Awards